Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice

Xiulan Chen,Xin Lin,Lihuan Xu,Yu Liu,Xin Liu,Chunhui Zhang,Baosong Xie
DOI: https://doi.org/10.1515/biol-2022-0860
2024-05-30
Open Life Sciences
Abstract:The aim of this study is to observe the changes in autophagy activities in lung tissues of mice with different degrees of pulmonary fibrosis (PF), and explore the association between PF and autophagy activity. The PF model was established by bleomycin (BLM, 25 and 35 mg/kg) atomization inhalation in C57BL/6 mice, samples were collected on the 7, 14, and 28 days after BLM administration. Hematoxylin–eosin staining was used to observe the pathological changes in lung tissues. Masson staining was utilized to assess areas of blue collagen fiber deposition in lung tissues. Quantitative real time polymerase chain reaction was used to detect the mRNA expressions of autophagy-related genes, including Atg5, Atg7, and Atg10 in lung tissues. Western blot was used to detect the protein expressions of autophagy-related genes, including p62 and LC3II/LC3I in lung tissues. Compared with control group, BLM dose-dependently decreased PaO 2 , mRNA expressions of Atg5, Atg7, Atg10, and LC3II/LC3I, while increased lung wet weight, lung coefficient, PF score, the blue area of collagen fibers, and p62 protein on the 7th, 14th, and 28th days. In conclusion, the more severe the PF induced by BLM, the lower the autophagy activity.
biology
What problem does this paper attempt to address?
The problem this paper attempts to address is the observation of changes in autophagic activity in mouse models of pulmonary fibrosis (PF) with varying degrees of severity, and to explore the relationship between pulmonary fibrosis and autophagic activity. Specifically, the study addresses this problem through the following methods: 1. **Establishment of pulmonary fibrosis model**: Using different doses of bleomycin (BLM) administered via aerosol inhalation to establish a pulmonary fibrosis model in C57BL/6 mice. 2. **Sample collection**: Collecting samples on days 7, 14, and 28 after BLM administration. 3. **Pathological examination**: Using hematoxylin-eosin staining (HE staining) to observe pathological changes in lung tissue, and using Masson staining to assess the deposition area of blue collagen fibers in lung tissue. 4. **Gene expression detection**: Using quantitative real-time polymerase chain reaction (qRT-PCR) to detect the mRNA expression of autophagy-related genes (such as Atg5, Atg7, and Atg10) in lung tissue. 5. **Protein expression detection**: Using Western blot to detect the expression of autophagy-related proteins (such as p62 and LC3II/LC3I) in lung tissue. Through these methods, the study found that as the severity of pulmonary fibrosis increased, autophagic activity gradually decreased. This provides important clues for further understanding the pathogenesis of pulmonary fibrosis.